List of articles with "CAR-T therapy"

AbelZeta's FDA Milestone

AbelZeta's FDA Milestone

United States Rockville CAR-T therapy AbelZeta Prizlon-cel
Vector BioMed's Recognition

Vector BioMed's Recognition

United States CAR-T therapy Gaithersburg Lentiviral Vector Vector BioMed
FUCASO Launch in Singapore

FUCASO Launch in Singapore

Singapore CAR-T therapy IASO Bio FUCASO
Jiahui Launches CAR-T Center

Jiahui Launches CAR-T Center

China Shanghai CAR-T therapy Jiahui Health International Medicine
Jiahui Cell Therapy Center

Jiahui Cell Therapy Center

China Shanghai CAR-T therapy Medical Innovation Jiahui Health
CREATE Medicines Workshop

CREATE Medicines Workshop

South Korea Seoul CAR-T therapy Autoimmune Disease CREATE Medicines
Innovations in CAR-T Therapy

Innovations in CAR-T Therapy

Canada Toronto CAR-T therapy mRNA Technology LNP Technology
Ovarian Cancer Keynote

Ovarian Cancer Keynote

United States Anixa Biosciences Rochester CAR-T therapy Ovarian Cancer
Cellex Reaches 10,000 Batches

Cellex Reaches 10,000 Batches

CAR-T therapy Cologne Cellex Cell Professionals autologous therapy
Ovarian Cancer CAR-T Trial

Ovarian Cancer CAR-T Trial

USA Anixa Biosciences CAR-T therapy San Jose, California Ovarian Cancer
Anixa CAR-T Trial Updates

Anixa CAR-T Trial Updates

United States Anixa Biosciences San Jose CAR-T therapy Ovarian Cancer
FUCASO Myeloma Insights

FUCASO Myeloma Insights

China Shanghai CAR-T therapy IASO Bio FUCASO
Milestone in Myeloma Therapy

Milestone in Myeloma Therapy

China Shanghai CAR-T therapy IASO Bio Myeloma Treatment
IASO Bio's CAR-T Therapy

IASO Bio's CAR-T Therapy

United States CAR-T therapy Pleasanton IASO Bio IASO208
Promising Therapy for Lymphomas

Promising Therapy for Lymphomas

USA Irvine CAR-T therapy PeproMene Bio PMB-CT01
Anixa at Nasdaq Summit

Anixa at Nasdaq Summit

United States Anixa Biosciences San Francisco CAR-T therapy Cleveland Clinic
Fast Track for MT027

Fast Track for MT027

USA Beijing CAR-T therapy T-MAXIMUM MT027
Anixa's Ovarian Cancer Advances

Anixa's Ovarian Cancer Advances

USA Anixa Biosciences San Jose CAR-T therapy Breast Cancer Vaccine
FDA Approval for RXIM002

FDA Approval for RXIM002

USA Cambridge CAR-T therapy RiboX RXIM002
Innovative CAR-T Trial Launch

Innovative CAR-T Trial Launch

United States Cambridge CAR-T therapy CREATE Medicines CRT-402
AbelZeta CAR-T Therapy Insights

AbelZeta CAR-T Therapy Insights

USA Rockville CAR-T therapy AbelZeta GPC3
AllerGene CAR Technology

AllerGene CAR Technology

USA Boston CAR-T therapy AllerGene AI mast cell targeting
First CAR-T Patient

First CAR-T Patient

China Shanghai Cancer Treatment CAR-T therapy Jiahui International
CAR-T Therapy Launch

CAR-T Therapy Launch

China Shanghai Cancer Treatment CAR-T therapy Jiahui International
CAR-T Treatment Begins

CAR-T Treatment Begins

China Shanghai oncology CAR-T therapy Jiahui
Anixa's CAR-T Trial Milestone

Anixa's CAR-T Trial Milestone

USA Anixa Biosciences San Jose CAR-T therapy Ovarian Cancer
First Patient with CAR-T Therapy

First Patient with CAR-T Therapy

China Shanghai CAR-T therapy Satri-cel Jiahui International Cancer Center
First International CAR-T Patient

First International CAR-T Patient

China Shanghai CAR-T therapy Satri-cel Jiahui International
Anixa's Cancer Immunotherapy

Anixa's Cancer Immunotherapy

United States Anixa Biosciences San Jose CAR-T therapy Breast Cancer Vaccine
First CAR-T Therapy

First CAR-T Therapy

China Shanghai Cancer Treatment CAR-T therapy Jiahui Center
CAR-T Therapy for Patients

CAR-T Therapy for Patients

China Shanghai CAR-T therapy Satri-cel Jiahui Health
First CAR-T Therapy Approved

First CAR-T Therapy Approved

China Shanghai Cancer Treatment CAR-T therapy Jiahui International
First Solid Tumor CAR-T Approved

First Solid Tumor CAR-T Approved

China Shanghai CAR-T therapy Satri-cel Jiahui Health
First Solid Tumor CAR-T Approved

First Solid Tumor CAR-T Approved

China Shanghai CAR-T therapy Satri-cel Jiahui International
Tang Prize 2026 Recognition

Tang Prize 2026 Recognition

Taiwan Taipei CAR-T therapy Cellular Immunotherapy Tang Prize
Innovative CAR-T Therapy

Innovative CAR-T Therapy

United States Miami CAR-T therapy Florida International University Immune Cells
OriCell GPC3 CAR-T Progress

OriCell GPC3 CAR-T Progress

China Shanghai CAR-T therapy Hepatocellular Carcinoma OriCell
PeproMene Bio's EHA 2026 Presentation

PeproMene Bio's EHA 2026 Presentation

USA Irvine CAR-T therapy PeproMene Bio PMB-CT01
CAR-T Therapy Journey

CAR-T Therapy Journey

China Shanghai CAR-T therapy Jiahui Health Relapsed Lymphoma
CAR-T Therapy Journey

CAR-T Therapy Journey

China Shanghai CAR-T therapy lymphoma treatment Jiahui Health
CAR-T Journey to Shanghai

CAR-T Journey to Shanghai

China Shanghai CAR-T therapy Jiahui Health Relapsed Lymphoma
CAR-T Therapy Journey

CAR-T Therapy Journey

China Shanghai CAR-T therapy lymphoma treatment Jiahui Health
CREATE Medicines Funding

CREATE Medicines Funding

USA Cambridge CAR-T therapy Series B CREATE Medicines
Caring Cross CAR-T Therapy

Caring Cross CAR-T Therapy

United States Boston CAR-T therapy Caring Cross HIV Research
Vivacta Bio Funding

Vivacta Bio Funding

China Shanghai CAR-T therapy Series A Funding Vivacta Biotechnology
Anixa CAR-T Therapy Presentation

Anixa CAR-T Therapy Presentation

United States Anixa Biosciences San Jose CAR-T therapy Ovarian Cancer
Minaris & Chimeric CAR-T

Minaris & Chimeric CAR-T

USA Philadelphia CAR-T therapy Minaris Advanced Therapies Chimeric Therapeutics
Lilly Acquires Kelonia

Lilly Acquires Kelonia

United States Indianapolis CAR-T therapy Eli Lilly Kelonia Therapeutics
Immunofoco IMV102 Data

Immunofoco IMV102 Data

China Shanghai CAR-T therapy Immunofoco IMV102
BioOra & Cincinnati Children's CAR-T

BioOra & Cincinnati Children's CAR-T

Cincinnati CAR-T therapy Cincinnati Children's BioOra

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.